There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Infect Disease Doctors Med Grp(4.7 mi away)Contact
+167 other location
The purpose of this study is to measure how well LY3819253 and LY3832479 work against the
virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early
symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of
the nose to determine how much virus is in the body at various times during the study.
Participation could last about 12 weeks and includes one required visit to the study site,
with the remainder of assessments performed in the home or by phone.
Clinical Study Identifier
Eli Lilly and Company
Last Modified on
18 January 2021
How clear was the trial content above?
Adding a note
Select a piece of text and start making personal notes.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.